Roth, Theodore L.
Puig-Saus, Cristina
Yu, Ruby
Shifrut, Eric
Carnevale, Julia
Li, P. Jonathan
Hiatt, Joseph
Saco, Justin
Krystofinski, Paige
Li, Han
Tobin, Victoria
Nguyen, David N.
Lee, Michael R.
Putnam, Amy L.
Ferris, Andrea L.
Chen, Jeff W.
Schickel, Jean-Nicolas
Pellerin, Laurence
Carmody, David
Alkorta-Aranburu, Gorka
del Gaudio, Daniela
Matsumoto, Hiroyuki
Morell, Montse
Mao, Ying
Cho, Min
Quadros, Rolen M.
Gurumurthy, Channabasavaiah B.
Smith, Baz
Haugwitz, Michael
Hughes, Stephen H.
Weissman, Jonathan S.
Schumann, Kathrin
Esensten, Jonathan H.
May, Andrew P.
Ashworth, Alan
Kupfer, Gary M.
Greeley, Siri Atma W.
Bacchetta, Rosa
Meffre, Eric
Roncarolo, Maria Grazia
Romberg, Neil
Herold, Kevan C.
Ribas, Antoni
Leonetti, Manuel D.
Marson, Alexander
Article History
Received: 19 November 2017
Accepted: 4 June 2018
First Online: 11 July 2018
Competing interests
: A.M. is a co-founder of Spotlight Therapeutics. A.M. serves as an advisor to Juno Therapeutics and is a member of the scientific advisory board of PACT Pharma. The Marson laboratory has received sponsored research support (Juno Therapeutics, Epinomics, Sanofi) and a gift from Gilead. A.R. is co-founder and a member of the scientific advisory board of PACT Pharma. T.L.R., C.P.S., E.S., A.R. and A.M. are inventors on new patent applications related to this manuscript (US patent application no. 62/520,117, T.L.R. and A.M.; US patent application no. 62/578,153, T.L.R., C.P.S., E.S., A.R. and A.M.).